Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Therapeutic Drug Carrier Systems
Fator do impacto: 2.9 FI de cinco anos: 3.72 SJR: 0.736 SNIP: 0.551 CiteScore™: 2.43

ISSN Imprimir: 0743-4863
ISSN On-line: 2162-660X

Volumes:
Volume 36, 2019 Volume 35, 2018 Volume 34, 2017 Volume 33, 2016 Volume 32, 2015 Volume 31, 2014 Volume 30, 2013 Volume 29, 2012 Volume 28, 2011 Volume 27, 2010 Volume 26, 2009 Volume 25, 2008 Volume 24, 2007 Volume 23, 2006 Volume 22, 2005 Volume 21, 2004 Volume 20, 2003 Volume 19, 2002 Volume 18, 2001 Volume 17, 2000 Volume 16, 1999 Volume 15, 1998 Volume 14, 1997 Volume 13, 1996 Volume 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v29.i3.10
pages 183-218

Pharmaceutical Cocrystals: A Novel Approach for Oral Bioavailability Enhancement of Drugs

Renu Chadha
University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, INDIA
Anupam Saini
University Institute of Pharmaceutical Sciences, Panjab University
Poonam Arora
University Institute of Pharmaceutical Sciences, Panjab University
Swati Bhandari
University Institute of Pharmaceutical Sciences, Panjab University

RESUMO

Solid dosage forms are by far the preferred drug delivery systems. However, these often face the problem of poor and erratic bioavailability during the drug development process. Numerous formulation strategies for drug delivery are currently under development, among which the solid forms such as polymorphs, solvates, salts, and cocrystals have been considered to be the most important for improving dissolution rate and bioavailability. Cocrystallization is a fairly new approach in pharmaceutical industry that can improve the solubility and, consequently, the bioactivity of the active pharmaceutical ingredient (API) without compromising its structural integrity. Pharmaceutical cocrystals have found their place in drug delivery, primarily due to their ability to produce alternative, viable solid forms when a more standard approach of salt and polymorph formation fails to deliver the desired objectives. Over the past few years, a number of papers have been published focusing on a broad range of subjects, from traditional crystal engineering to structure-property relationships of cocrystals. The present review, however, illustrates how the cocrystalline forms of APIs have improved their in vitro dissolution rate and in vivo bioavailability, often correlating well with their improved solubility as well.


Articles with similar content:

Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.26, 2009, issue 6
Eliahu Heldman, Kristin Loomis, Brandon Smith, Anu Puri, Jae-Ho Lee, Amichai Yavlovich, Robert Blumenthal
Herbal Medicines in Neurodegenerative Disorders: An Evolutionary Approach through Novel Drug Delivery System
Journal of Environmental Pathology, Toxicology and Oncology, Vol.37, 2018, issue 3
Sunil Kumar Dubey, Gaurav Gupta, Ranendra Narayan Saha, Kowthavarapu Venkata Krishna, Gautam Singhvi, Tejas Agnihotri
Physical Chemical Considerations of Lipid-Based Oral Drug Delivery—Solid Lipid Nanoparticles
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.21, 2004, issue 1
Paul M. Bummer
Lipid Materials for Topical and Transdermal Delivery of Nanoemulsions
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.31, 2014, issue 5
R. Jayachandra Babu, Kasturi R. Pawar
Nanostructured Materials in Drug and Gene Delivery: A Review of the State of the Art
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.28, 2011, issue 2
Krutika Sawant, Kailash C. Petkar, Sandip S. Chavhan, Snezana Agatonovik-Kustrin